Uterine activity and blood flow in response to sulprostone during midtrimester pregnancy termination.
D000029:Abortion, Legal; D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology* / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects*; D014592:Uterine Hemorrhage / Q000188:drug therapy; D014599:Uterus / Q000098:blood supply / Q000187:drug effects*
D011459:Prostaglandins E, Synthetic; C016767:sulprostone; D015232:Dinoprostone